Alnylam Pharmaceuticals, Inc.
DE ˙ XTRA ˙ US02043Q1076
260,50 € ↑8,70 (3,46%)
2026-06-04
DEL PRIS
SecurityDE:DUL / Alnylam Pharmaceuticals, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership23,415 shares
Latest Disclosed Value $ 7,747,321
Citadel Advisors Llc ownership in DUL / Alnylam Pharmaceuticals, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 23,415 shares of Alnylam Pharmaceuticals, Inc. (DE:DUL) valued at $6,689,666 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 38,459 shares of Alnylam Pharmaceuticals, Inc.. This represents a change in shares of -39.12% during the quarter. The current value of the position is $6,099,608 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (DUL) in the form of stock options. The firm currently holds call options representing 50,600 of underlying shares valued at $16,742,022 USD and put options representing 37,200 of underlying shares valued at $12,308,364 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:DUL / Alnylam Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 23,415 -15,044 -39.12 7,747 -49.34 0.0011
2026-02-17 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 38,459 -183,384 -82.66 15,293 -84.88 0.0023
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 221,843 -379,356 -63.10 101,160 -48.40 0.0154
2025-08-14 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 601,199 596,963 14,092.61 196,045 17,051.71 0.0340
2025-05-15 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 4,236 -61,157 -93.52 1,144 -92.57 0.0002
2025-02-14 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 65,393 41,461 173.25 15,388 133.77 0.0027
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 23,932 -343,357 -93.48 6,582 -92.63 0.0013
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 367,289 327,305 818.59 89,251 1,393.74 0.0181
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 39,984 -26,665 -40.01 5,976 -53.16 0.0012
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 66,649 66,649 12,757 0.0025
2023-11-14 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -29,563 -100.00 0 -100.00
2023-08-14 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 29,563 -74,773 -71.67 5,615 -73.13 0.0012
2023-05-15 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 104,336 102,896 7,145.56 20,901 6,011.11 0.0046
2023-02-14 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 1,440 -81,132 -98.26 342 -97.93 0.0001
2022-11-14 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 82,572 74,878 973.20 16,527 1,371.68 0.0038
2022-08-15 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 7,694 5,586 264.99 1,123 226.45 0.0003
2022-05-16 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 2,108 -68,660 -97.02 344 -97.13 0.0001
2022-02-14 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 70,768 49,889 238.94 12,001 204.44 0.0025
2021-11-15 2021-09-30 13F ALNYLAM PHARMACEUTICALS Cmn 02043Q107 20,879 -18,070 -46.39 3,942 -40.30 0.0008
2021-08-16 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 38,949 -84,277 -68.39 6,603 -62.05 0.0015
2021-05-21 2021-03-31 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 123,226 42,265 52.20 17,398 65.35 0.0043
2021-05-17 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 123,226 42,265 17,398 0.0043
2021-02-16 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 80,961 54,428 205.13 10,522 172.38 0.0027
2020-11-16 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 26,533 -47,167 -64.00 3,863 -64.61 0.0011
2020-08-14 2020-06-30 13F ALNYLAM PHARMACEUTICALS Cmn 02043Q107 73,700 -36,658 -33.22 10,916 -9.13 0.0039
2020-05-15 2020-03-31 13F ALNYLAM PHARMACEUTICALS Cmn 02043Q107 110,358 29,585 36.63 12,013 29.13 0.0054
2020-02-14 2019-12-31 13F ALNYLAM PHARMACEUTICALS Cmn 02043Q107 80,773 367 0.46 9,303 43.88 0.0040
2019-11-14 2019-09-30 13F ALNYLAM PHARMACEUTICALS Cmn 02043Q107 80,406 -885,638 -91.68 6,466 -90.78 0.0030
2019-08-14 2019-06-30 13F ALNYLAM PHARMACEUTICALS Cmn 02043Q107 966,044 953,740 7,751.46 70,096 5,995.30 0.0321
2019-05-15 2019-03-31 13F ALNYLAM PHARMACEUTICALS Cmn 02043Q107 12,304 -17,316 -58.46 1,150 -46.76 0.0006
2019-02-14 2018-12-31 13F ALNYLAM PHARMACEUTICALS Cmn 02043Q107 29,620 -5,856 -16.51 2,160 -30.43 0.0012
2018-11-13 2018-09-30 13F ALNYLAM PHARMACEUTICALS Cmn 02043Q107 35,476 -1,212 -3.30 3,105 -14.06 0.0014
2018-08-14 2018-06-30 13F/A-1 ALNYLAM PHARMACEUTICALS Cmn 02043Q107 36,688 36,688 3,613 0.0018
2018-08-10 2018-06-30 13F ALNYLAM PHARMACEUTICALS Cmn 02043Q107 36,688 36,688 3,613
2018-05-14 2018-03-31 13F/A-1 ALNYLAM PHARMACEUTICALS Cmn 02043Q107 0 -57,507 -100.00 0 -100.00
2018-02-09 2017-12-31 13F ALNYLAM PHARMACEUTICALS Cmn 02043Q107 57,507 12,286 27.17 7,307 37.53 0.0044
2017-11-09 2017-09-30 13F ALNYLAM PHARMACEUTICALS Cmn 02043Q107 45,221 45,221 5,313 0.0041
2017-05-12 2017-03-31 13F ALNYLAM PHARMACEUTICALS Cmn 02043Q107 0 -9,632 -100.00 0 -100.00
2017-02-10 2016-12-31 13F ALNYLAM PHARMACEUTICALS Cmn 02043Q107 9,632 9,632 361 0.0004
2016-08-12 2016-06-30 13F ALNYLAM PHARMACEUTICALS INC. Cmn 02043Q107 0 -730,736 -100.00 0 -100.00
2017-01-31 2016-03-31 13F/A-1 ALNYLAM PHARMACEUTICALS Cmn 02043Q107 730,736 549,198 302.53 45,868 168.39 0.0579
2016-05-13 2016-03-31 13F ALNYLAM PHARMACEUTICALS INC. Cmn 02043Q107 730,736 45,868
2017-01-31 2015-12-31 13F/A-1 ALNYLAM PHARMACEUTICALS Cmn 02043Q107 181,538 42,110 30.20 17,090 52.53 0.0187
2016-02-12 2015-12-31 13F ALNYLAM PHARMACEUTICALS INC. Cmn 02043Q107 181,538 17,090
2015-11-16 2015-09-30 13F ALNYLAM PHARMACEUTICALS INC. Cmn 02043Q107 139,428 135,409 3,369.22 11,204 2,224.48 0.0108
2015-08-14 2015-06-30 13F ALNYLAM PHARMACEUTICALS INC. Cmn 02043Q107 4,019 -111 -2.69 482 11.83 0.0004
2015-05-15 2015-03-31 13F ALNYLAM PHARMACEUTICALS INC. Cmn 02043Q107 4,130 -5,410 -56.71 431 -53.41 0.0005
2015-02-17 2014-12-31 13F ALNYLAM PHARMACEUTICALS INC. Cmn 02043Q107 9,540 -241,810 -96.20 925 -95.29 0.0011
2014-11-14 2014-09-30 13F ALNYLAM PHARMACEUTICALS INC. Cmn 02043Q107 251,350 249,369 12,588.04 19,631 15,604.80 0.0246
2014-08-14 2014-06-30 13F ALNYLAM PHARMACEUTICALS INC. Cmn 02043Q107 1,981 -24,538 -92.53 125 -92.98 0.0002
2014-05-15 2014-03-31 13F ALNYLAM PHARMACEUTICALS INC. Cmn 02043Q107 26,519 -246,700 -90.29 1,781 -89.82 0.0025
2013-11-14 2013-09-30 13F ALNYLAM PHARMACEUTICALS INC. Cmn 02043Q107 273,219 -914,677 -77.00 17,489 -52.52 0.0267
2013-08-14 2013-06-30 13F ALNYLAM PHARMACEUTICALS INC. Cmn 02043Q107 1,187,896 1,187,896 36,836 0.0636
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 50,600 -12.31 16,742 -27.03 n/a n/a n/a
2026-02-17 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 57,700 19.21 22,944 3.96 n/a n/a n/a
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 48,400 -19.73 22,070 12.24 n/a n/a n/a
2025-08-14 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 60,300 -27.78 19,663 -12.79 n/a n/a n/a
2025-05-15 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 83,500 -19.17 22,547 -7.24 n/a n/a n/a
2025-02-14 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 103,300 -32.75 24,308 -42.46 n/a n/a n/a
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 153,600 -39.84 42,245 -31.91 n/a n/a n/a
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 255,300 -0.66 62,038 61.52 n/a n/a n/a
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 257,000 75.31 38,409 36.88 n/a n/a n/a
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 146,600 33.88 28,061 44.70 n/a n/a n/a
2023-11-14 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 109,500 17.87 19,392 9.90 n/a n/a n/a
2023-08-14 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 92,900 -16.61 17,645 -20.93 n/a n/a n/a
2023-05-15 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 111,400 -34.85 22,316 -45.09 n/a n/a n/a
2023-02-14 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 171,000 -4.79 40,638 13.04 n/a n/a n/a
2022-11-14 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 179,600 -49.93 35,949 -31.28 n/a n/a n/a
2022-08-15 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 358,700 305.31 52,316 262.02 n/a n/a n/a
2022-05-16 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 88,500 -7.33 14,451 -10.77 n/a n/a n/a
2022-02-14 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 95,500 42.96 16,195 28.40 n/a n/a n/a
2021-11-15 2021-09-30 13F ALNYLAM PHARMACEUTICALS Cmn Call 66,800 -11.52 12,613 -1.45 n/a n/a n/a
2021-08-16 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 75,500 54.40 12,799 85.39 n/a n/a n/a
2021-05-21 2021-03-31 13F/A ALNYLAM PHARMACEUTICALS COM Call 48,900 8.43 6,904 17.78 n/a n/a n/a
2021-05-17 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 48,900 6,904 n/a n/a n/a
2021-02-16 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 45,100 -36.21 5,862 -43.05 n/a n/a n/a
2020-11-16 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 70,700 -4.85 10,294 -6.46 n/a n/a n/a
2020-08-14 2020-06-30 13F ALNYLAM PHARMACEUTICALS Cmn Call 74,300 25.08 11,005 70.20 n/a n/a n/a
2020-05-15 2020-03-31 13F ALNYLAM PHARMACEUTICALS Cmn Call 59,400 -44.74 6,466 -47.77 n/a n/a n/a
2020-02-14 2019-12-31 13F ALNYLAM PHARMACEUTICALS Cmn Call 107,500 -41.35 12,381 -16.01 n/a n/a n/a
2019-11-14 2019-09-30 13F ALNYLAM PHARMACEUTICALS Cmn Call 183,300 515.10 14,741 581.82 n/a n/a n/a
2019-08-14 2019-06-30 13F ALNYLAM PHARMACEUTICALS Cmn Call 29,800 -64.98 2,162 -72.82 n/a n/a n/a
2019-05-15 2019-03-31 13F ALNYLAM PHARMACEUTICALS Cmn Call 85,100 -17.22 7,953 6.11 n/a n/a n/a
2019-02-14 2018-12-31 13F ALNYLAM PHARMACEUTICALS Cmn Call 102,800 -40.47 7,495 -50.41 n/a n/a n/a
2018-11-13 2018-09-30 13F ALNYLAM PHARMACEUTICALS Cmn Call 172,700 92.75 15,115 71.27 n/a n/a n/a
2018-08-14 2018-06-30 13F/A ALNYLAM PHARMACEUTICALS Cmn Call 89,600 70.02 8,825 40.59 n/a n/a n/a
2018-08-10 2018-06-30 13F ALNYLAM PHARMACEUTICALS Cmn Call 89,600 8,825 n/a n/a n/a
2018-05-14 2018-03-31 13F/A ALNYLAM PHARMACEUTICALS Cmn Call 52,700 36.18 6,277 27.66 n/a n/a n/a
2018-05-11 2018-03-31 13F ALNYLAM PHARMACEUTICALS Cmn Call 52,700 6,277 n/a n/a n/a
2018-02-09 2017-12-31 13F ALNYLAM PHARMACEUTICALS Cmn Call 38,700 -68.61 4,917 -66.06 n/a n/a n/a
2017-11-09 2017-09-30 13F ALNYLAM PHARMACEUTICALS Cmn Call 123,300 356.67 14,487 572.56 n/a n/a n/a
2017-08-11 2017-06-30 13F ALNYLAM PHARMACEUTICALS Cmn Call 27,000 23.29 2,154 91.98 n/a n/a n/a
2017-05-12 2017-03-31 13F ALNYLAM PHARMACEUTICALS Cmn Call 21,900 -14.45 1,122 17.12 n/a n/a n/a
2017-02-10 2016-12-31 13F ALNYLAM PHARMACEUTICALS Cmn Call 25,600 -3.03 958 -46.45 n/a n/a n/a
2017-01-31 2016-09-30 13F/A ALNYLAM PHARMACEUTICALS Cmn Call 26,400 63.98 1,789 100.34 n/a n/a n/a
2016-11-10 2016-09-30 13F ALNYLAM PHARMACEUTICALS INC. Cmn Call 26,400 1,789 n/a n/a n/a
2017-01-31 2016-06-30 13F/A ALNYLAM PHARMACEUTICALS Cmn Call 16,100 -39.93 893 -46.91 n/a n/a n/a
2016-08-12 2016-06-30 13F ALNYLAM PHARMACEUTICALS INC. Cmn Call 16,100 893 n/a n/a n/a
2017-01-31 2016-03-31 13F/A ALNYLAM PHARMACEUTICALS Cmn Call 26,800 155.24 1,682 70.24 n/a n/a n/a
2016-05-13 2016-03-31 13F ALNYLAM PHARMACEUTICALS INC. Cmn Call 26,800 1,682 n/a n/a n/a
2017-01-31 2015-12-31 13F/A ALNYLAM PHARMACEUTICALS Cmn Call 10,500 -80.41 988 -77.06 n/a n/a n/a
2016-02-12 2015-12-31 13F ALNYLAM PHARMACEUTICALS INC. Cmn Call 10,500 988 n/a n/a n/a
2015-11-16 2015-09-30 13F ALNYLAM PHARMACEUTICALS INC. Cmn Call 53,600 -16.90 4,307 -44.30 n/a n/a n/a
2015-08-14 2015-06-30 13F ALNYLAM PHARMACEUTICALS INC. Cmn Call 64,500 28.74 7,732 47.81 n/a n/a n/a
2015-05-15 2015-03-31 13F ALNYLAM PHARMACEUTICALS INC. Cmn Call 50,100 163.68 5,231 183.83 n/a n/a n/a
2015-02-17 2014-12-31 13F ALNYLAM PHARMACEUTICALS INC. Cmn Call 19,000 -18.80 1,843 0.82 n/a n/a n/a
2014-11-14 2014-09-30 13F ALNYLAM PHARMACEUTICALS INC. Cmn Call 23,400 93.39 1,828 139.27 n/a n/a n/a
2014-08-14 2014-06-30 13F ALNYLAM PHARMACEUTICALS INC. Cmn Call 12,100 -23.90 764 -28.46 n/a n/a n/a
2014-05-15 2014-03-31 13F ALNYLAM PHARMACEUTICALS INC. Cmn Call 15,900 3.25 1,068 7.77 n/a n/a n/a
2014-02-14 2013-12-31 13F ALNYLAM PHARMACEUTICALS Cmn Call 15,400 -31.56 991 -31.18 n/a n/a n/a
2013-11-14 2013-09-30 13F ALNYLAM PHARMACEUTICALS INC. Cmn Call 22,500 75.78 1,440 262.72 n/a n/a n/a
2013-08-14 2013-06-30 13F ALNYLAM PHARMACEUTICALS INC. Cmn Call 12,800 397 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 37,200 -58.71 12,308 -65.65 n/a n/a n/a
2026-02-17 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 90,100 27.26 35,828 10.98 n/a n/a n/a
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 70,800 80.15 32,285 151.92 n/a n/a n/a
2025-08-14 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 39,300 -23.84 12,815 -8.02 n/a n/a n/a
2025-05-15 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 51,600 -11.64 13,933 1.39 n/a n/a n/a
2025-02-14 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 58,400 -56.80 13,742 -63.04 n/a n/a n/a
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 135,200 -4.99 37,184 7.54 n/a n/a n/a
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 142,300 3.19 34,579 67.78 n/a n/a n/a
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 137,900 24.12 20,609 -3.08 n/a n/a n/a
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 111,100 17.32 21,266 26.80 n/a n/a n/a
2023-11-14 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 94,700 -11.66 16,771 -17.63 n/a n/a n/a
2023-08-14 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 107,200 -28.29 20,362 -32.01 n/a n/a n/a
2023-05-15 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 149,500 31.14 29,948 10.54 n/a n/a n/a
2023-02-14 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 114,000 -7.09 27,092 10.31 n/a n/a n/a
2022-11-14 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 122,700 -32.69 24,560 -7.63 n/a n/a n/a
2022-08-15 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 182,300 93.94 26,588 73.22 n/a n/a n/a
2022-05-16 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 94,000 -21.99 15,349 -24.88 n/a n/a n/a
2022-02-14 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 120,500 64.17 20,434 47.44 n/a n/a n/a
2021-11-15 2021-09-30 13F ALNYLAM PHARMACEUTICALS Cmn Put 73,400 -14.65 13,859 -4.94 n/a n/a n/a
2021-08-16 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 86,000 228.24 14,579 294.13 n/a n/a n/a
2021-05-21 2021-03-31 13F/A ALNYLAM PHARMACEUTICALS COM Put 26,200 -54.83 3,699 -50.93 n/a n/a n/a
2021-05-17 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 26,200 3,699 n/a n/a n/a
2021-02-16 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 58,000 -11.99 7,538 -21.44 n/a n/a n/a
2020-11-16 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 65,900 -3.80 9,595 -5.43 n/a n/a n/a
2020-08-14 2020-06-30 13F ALNYLAM PHARMACEUTICALS Cmn Put 68,500 9.78 10,146 49.38 n/a n/a n/a
2020-05-15 2020-03-31 13F ALNYLAM PHARMACEUTICALS Cmn Put 62,400 22.83 6,792 16.08 n/a n/a n/a
2020-02-14 2019-12-31 13F ALNYLAM PHARMACEUTICALS Cmn Put 50,800 51.64 5,851 117.19 n/a n/a n/a
2019-11-14 2019-09-30 13F ALNYLAM PHARMACEUTICALS Cmn Put 33,500 -45.44 2,694 -39.53 n/a n/a n/a
2019-08-14 2019-06-30 13F ALNYLAM PHARMACEUTICALS Cmn Put 61,400 6.23 4,455 -17.52 n/a n/a n/a
2019-05-15 2019-03-31 13F ALNYLAM PHARMACEUTICALS Cmn Put 57,800 -36.48 5,401 -18.60 n/a n/a n/a
2019-02-14 2018-12-31 13F ALNYLAM PHARMACEUTICALS Cmn Put 91,000 22.81 6,635 2.31 n/a n/a n/a
2018-11-13 2018-09-30 13F ALNYLAM PHARMACEUTICALS Cmn Put 74,100 15.96 6,485 3.03 n/a n/a n/a
2018-08-14 2018-06-30 13F/A ALNYLAM PHARMACEUTICALS Cmn Put 63,900 100.94 6,294 66.20 n/a n/a n/a
2018-08-10 2018-06-30 13F ALNYLAM PHARMACEUTICALS Cmn Put 63,900 6,294 n/a n/a n/a
2018-05-14 2018-03-31 13F/A ALNYLAM PHARMACEUTICALS Cmn Put 31,800 -49.44 3,787 -52.61 n/a n/a n/a
2018-05-11 2018-03-31 13F ALNYLAM PHARMACEUTICALS Cmn Put 31,800 3,787 n/a n/a n/a
2018-02-09 2017-12-31 13F ALNYLAM PHARMACEUTICALS Cmn Put 62,900 -31.85 7,991 -26.31 n/a n/a n/a
2017-11-09 2017-09-30 13F ALNYLAM PHARMACEUTICALS Cmn Put 92,300 409.94 10,844 650.97 n/a n/a n/a
2017-08-11 2017-06-30 13F ALNYLAM PHARMACEUTICALS Cmn Put 18,100 -11.71 1,444 37.39 n/a n/a n/a
2017-05-12 2017-03-31 13F ALNYLAM PHARMACEUTICALS Cmn Put 20,500 39.46 1,051 91.09 n/a n/a n/a
2017-02-10 2016-12-31 13F ALNYLAM PHARMACEUTICALS Cmn Put 14,700 59.78 550 -11.86 n/a n/a n/a
2017-01-31 2016-09-30 13F/A ALNYLAM PHARMACEUTICALS Cmn Put 9,200 -44.58 624 -32.25 n/a n/a n/a
2016-11-10 2016-09-30 13F ALNYLAM PHARMACEUTICALS INC. Cmn Put 9,200 624 n/a n/a n/a
2017-01-31 2016-06-30 13F/A ALNYLAM PHARMACEUTICALS Cmn Put 16,600 9.21 921 -3.46 n/a n/a n/a
2016-08-12 2016-06-30 13F ALNYLAM PHARMACEUTICALS INC. Cmn Put 16,600 921 n/a n/a n/a
2017-01-31 2016-03-31 13F/A ALNYLAM PHARMACEUTICALS Cmn Put 15,200 2.01 954 -32.00 n/a n/a n/a
2016-05-13 2016-03-31 13F ALNYLAM PHARMACEUTICALS INC. Cmn Put 15,200 954 n/a n/a n/a
2017-01-31 2015-12-31 13F/A ALNYLAM PHARMACEUTICALS Cmn Put 14,900 -57.06 1,403 -49.68 n/a n/a n/a
2016-02-12 2015-12-31 13F ALNYLAM PHARMACEUTICALS INC. Cmn Put 14,900 1,403 n/a n/a n/a
2015-11-16 2015-09-30 13F ALNYLAM PHARMACEUTICALS INC. Cmn Put 34,700 -35.74 2,788 -56.93 n/a n/a n/a
2015-08-14 2015-06-30 13F ALNYLAM PHARMACEUTICALS INC. Cmn Put 54,000 94.95 6,473 123.82 n/a n/a n/a
2015-05-15 2015-03-31 13F ALNYLAM PHARMACEUTICALS INC. Cmn Put 27,700 88.44 2,892 102.81 n/a n/a n/a
2015-02-17 2014-12-31 13F ALNYLAM PHARMACEUTICALS INC. Cmn Put 14,700 34.86 1,426 67.57 n/a n/a n/a
2014-11-14 2014-09-30 13F ALNYLAM PHARMACEUTICALS INC. Cmn Put 10,900 -10.66 851 10.38 n/a n/a n/a
2014-08-14 2014-06-30 13F ALNYLAM PHARMACEUTICALS INC. Cmn Put 12,200 -31.84 771 -35.86 n/a n/a n/a
2014-05-15 2014-03-31 13F ALNYLAM PHARMACEUTICALS INC. Cmn Put 17,900 75.49 1,202 83.23 n/a n/a n/a
2014-02-14 2013-12-31 13F ALNYLAM PHARMACEUTICALS Cmn Put 10,200 -34.19 656 -33.87 n/a n/a n/a
2013-11-14 2013-09-30 13F ALNYLAM PHARMACEUTICALS INC. Cmn Put 15,500 -28.90 992 46.75 n/a n/a n/a
2013-08-14 2013-06-30 13F ALNYLAM PHARMACEUTICALS INC. Cmn Put 21,800 676 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.